Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Shoulder Innovations to Participate in the Jefferies Global Healthcare Conference
-
ImmuCell Announces Onboarding of New CEO and Related Management Changes
-
Werner Enterprises to Participate in Four Investment Conferences
-
NeuroPace Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
-
Supermicro Announces First Quarter Fiscal Year 2026 Financial Results
-
Marvell Technology, Inc. Announces Conference Call to Review Third Quarter of Fiscal Year 2026 Financial Results
-
WESTERN MIDSTREAM ANNOUNCES RECORD THIRD-QUARTER 2025 RESULTS
-
Gilead Sciences to Present at Upcoming Investor Conferences
-
MaxLinear, Inc. Announces Fourth Quarter 2025 Financial Conference Participation
-
Rambus to Present at Upcoming Investor Conferences
-
Veracyte Announces Third Quarter 2025 Financial Results
-
BlueLinx Announces Third Quarter 2025 Results
-
Arteris Selected by Altera to Advance Intelligent Computing Across Cloud-to-Edge Applications
-
PennantPark Investment Corporation Announces Monthly Distribution of $0.08 per Share
-
Exelixis Announces Third Quarter 2025 Financial Results and Provides Corporate Update
-
Sana Biotechnology to Present at the TD Cowen Immunology & Inflammation Summit
-
Trex Company Reports Third Quarter 2025 Results
-
agilon health Reports Third Quarter 2025 Results and Re-Establishes Full Year Outlook
-
1stDibs to Participate in Upcoming Investor Conference
-
OnKure Therapeutics to Participate in Upcoming Investor Conferences
-
Aflac Incorporated Announces Third Quarter Results, Reports Third Quarter Net Earnings of $1.6 Billion, Declares Fourth Quarter Dividend
-
Oportun Delivers Fourth Consecutive Quarter of GAAP Profitability, Increases Full-Year 2025 Adjusted EPS Guidance
-
Canaan Inc. Announces Strategic Investment from Brevan Howard, Galaxy Digital, and Weiss Asset Management
-
OmniAb Reports Third Quarter 2025 Financial Results and Business Highlights
-
The Andersons, Inc. Reports Third Quarter Results
-
Upstart Announces Results for Third Quarter 2025
-
Corcept Therapeutics Announces Third Quarter Financial Results, Oncology Development Programs and Provides Corporate Update
-
RideNow Group, Inc. Reports Third Quarter 2025 Financial Results
-
KORU Medical Systems Announces Development Agreement for Innovation in Subcutaneous Immunoglobulin Infusion Systems
-
ProShares Announces ETF Share Splits
-
Ascent Industries Co. Delivers Strongest Earnings Since 2022; Gross Profit Nearly Doubles Year-Over-Year
-
Postal Realty Trust, Inc. Reports Third Quarter 2025 Results
-
The Tile Shop Reports Third Quarter 2025 Results
-
SuRo Capital Corp. Reports Third Quarter 2025 Financial Results
-
Ultragenyx Reports Third Quarter 2025 Financial Results and Corporate Update
-
Inspirato Reports Q3 Financial and Operating Results
-
Solana Company Files Application to Cease to Be a Reporting Issuer in Canada
-
Carlyle Secured Lending, Inc. Announces Financial Results For Third Quarter Ended September 30, 2025, Declares Fourth Quarter 2025 Dividend of $0.40 Per Common Share
-
Biomea Fusion Reports Third Quarter 2025 Financial Results and Corporate Highlights
-
Amwell® Announces Results for Third Quarter 2025
-
Weyco Group, Inc. Declares Special Cash Dividend
-
InnovAge Announces Financial Results for the Fiscal First Quarter Ended September 30, 2025
-
Immuneering to Report Third Quarter 2025 Financial Results and Provide New Clinical Case Studies, on Wednesday, November 12, 2025
-
Nasdaq Reports October 2025 Volumes
-
Workhorse Group Recommends Shareholders Follow Recommendations of Leading Independent Proxy Advisory Firms to Vote FOR Motiv Transaction Today
-
OrthoPediatrics to Participate in Upcoming Conferences
-
Comscore Reports Third Quarter 2025 Results
-
Kratos to Acquire Israel-Based Orbit Technologies Ltd for $356.3 Million
-
Vaxcyte Reports Third Quarter 2025 Financial Results and Provides Business Update Including Final Data from Positive VAX-24 Infant Phase 2 Dose-Finding Study
-
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

